New York City based Xalud Therapeutics is raising $30,000,001.00 in New Equity Investment.
New York City, NY – According to filings with the U.S. Securities and Exchange Commission, Xalud Therapeutics is raising $30,000,001.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Diem Nguyen…
